NMCC aggressively manages cancer and the side effects of the disease and treatment to help patients feel better and spend more time at home. We offer treatment until 6 p.m. during the week and from 1 to 4 p.m. on weekends so our patients don't have to seek care in the ER.
The FDA granted approval to nivolumab (Opdivo) for patients with renal cell carcinoma. Opdivo, a PD-1 inhibitor, was previously approved for the treatment of melanoma whose tumors express the B... Continue Reading
Prostate Cancer is the most common non-skin cancer in America, affecting 1 in 7 men; however, it is very treatable if detected early. Learn more about local resources and why it is important to get tested.
NMCC is amongst only five practices across the country – and the only one in New Mexico – to receive “full accreditation” status as an Oncology Medical Home (OMH) by the Commission on Cancer. Learn how this sets NMCC apart from all other providers in New Mexico.
New Mexico Cancer Center’s Radiation Oncology program is accredited by the American College of Radiology (ACR). The ACR seal of accreditation represents the highest level of quality and patient safety. Read more about why this is important for your care.